Holen Sie sich die Stockscreener-App
21.38
1.04%
0.22
Handel nachbörslich:
21.41
0.03
+0.14%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt LEVI?
Forum
Prognose
Dividendenhistorie
Schlusskurs vom Vortag:
$21.16
Offen:
$20.77
24-Stunden-Volumen:
3.79M
Relative Volume:
1.42
Marktkapitalisierung:
$2.29B
Einnahmen:
$6.16B
Nettoeinkommen (Verlust:
$155.00M
KGV:
56.26
EPS:
0.38
Netto-Cashflow:
$633.10M
1W Leistung:
-12.63%
1M Leistung:
-2.42%
6M Leistung:
+42.91%
1J Leistung:
+12.29%
1-Tages-Spanne:
$20.68
$21.57
1-Wochen-Bereich:
$20.68
$24.77
52-Wochen-Spanne:
$12.17
$24.82
Levi Strauss Co Stock (LEVI) Company Profile
Firmenname
Levi Strauss Co
Sektor
Branche
Telefon
(415) 501-6000
Adresse
1155 BATTERY ST, SAN FRANCISCO, CA
Vergleichen Sie LEVI mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LEVI
Levi Strauss Co
|
21.38 | 8.27B | 6.16B | 155.00M | 633.10M | 0.38 |
|
RL
Ralph Lauren Corp
|
317.92 | 19.22B | 7.29B | 794.70M | 763.80M | 12.53 |
|
GIL
Gildan Activewear Inc
|
60.67 | 9.02B | 3.23B | 421.86M | 384.54M | 2.53 |
|
VFC
Vf Corp
|
14.48 | 5.49B | 10.00B | -667.47M | 604.39M | -1.73 |
|
KTB
Kontoor Brands Inc
|
81.84 | 4.37B | 2.58B | 250.60M | 473.78M | 4.44 |
|
PVH
Pvh Corp
|
83.10 | 3.85B | 8.77B | 713.10M | 715.30M | 12.28 |
Levi Strauss Co Stock (LEVI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-03 | Bestätigt | Telsey Advisory Group | Outperform |
| 2025-09-25 | Eingeleitet | Needham | Buy |
| 2025-07-11 | Bestätigt | Telsey Advisory Group | Outperform |
| 2025-04-30 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-04-10 | Hochstufung | BofA Securities | Neutral → Buy |
| 2025-04-08 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2025-04-08 | Bestätigt | Telsey Advisory Group | Outperform |
| 2025-01-08 | Eingeleitet | Barclays | Overweight |
| 2024-06-21 | Bestätigt | Telsey Advisory Group | Outperform |
| 2024-06-14 | Eingeleitet | OTR Global | Positive |
| 2024-04-04 | Bestätigt | Telsey Advisory Group | Outperform |
| 2024-03-27 | Bestätigt | Telsey Advisory Group | Outperform |
| 2024-01-26 | Bestätigt | Telsey Advisory Group | Outperform |
| 2024-01-16 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2023-09-27 | Eingeleitet | TD Cowen | Outperform |
| 2023-01-23 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2023-01-18 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-01-11 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-12-12 | Herabstufung | Goldman | Buy → Neutral |
| 2022-08-04 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-27 | Bestätigt | BofA Securities | Buy |
| 2022-01-27 | Bestätigt | Citigroup | Buy |
| 2022-01-27 | Bestätigt | JP Morgan | Overweight |
| 2022-01-14 | Fortgesetzt | BofA Securities | Buy |
| 2021-08-30 | Eingeleitet | Wells Fargo | Overweight |
| 2021-08-02 | Eingeleitet | Stifel | Buy |
| 2021-07-14 | Eingeleitet | Goldman | Buy |
| 2021-04-09 | Bestätigt | Telsey Advisory Group | Outperform |
| 2021-04-01 | Bestätigt | Telsey Advisory Group | Outperform |
| 2021-01-25 | Bestätigt | Telsey Advisory Group | Outperform |
| 2020-12-10 | Hochstufung | Goldman | Sell → Buy |
| 2020-11-10 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-10-12 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-10-07 | Bestätigt | Telsey Advisory Group | Outperform |
| 2020-07-08 | Bestätigt | Telsey Advisory Group | Outperform |
| 2020-06-16 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2020-04-01 | Bestätigt | Telsey Advisory Group | Outperform |
| 2020-03-18 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2020-02-24 | Eingeleitet | UBS | Buy |
| 2019-10-22 | Eingeleitet | Macquarie | Outperform |
| 2019-10-09 | Bestätigt | BofA/Merrill | Buy |
| 2019-08-15 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-07-17 | Herabstufung | Goldman | Neutral → Sell |
| 2019-04-15 | Eingeleitet | BofA/Merrill | Neutral |
| 2019-04-15 | Eingeleitet | Citigroup | Buy |
| 2019-04-15 | Eingeleitet | Goldman | Neutral |
| 2019-04-15 | Eingeleitet | Guggenheim | Buy |
| 2019-04-15 | Eingeleitet | JP Morgan | Overweight |
| 2019-04-15 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2019-04-15 | Eingeleitet | Telsey Advisory Group | Outperform |
Alle ansehen
Levi Strauss Co Aktie (LEVI) Neueste Nachrichten
Broad Peak Investment Advisers Pte Ltd Acquires New Position in Levi Strauss & Co. $LEVI - MarketBeat
Levi's Denim, Campaigns Drive Higher Sales - MarketScreener
Levi's is latest to send customers disturbing message - TheStreet
Watch Levi's Denim, Campaigns Drive Higher Sales - Bloomberg.com
Levi’s News: HQ Store Reopens, The Vault Returns - Sourcing Journal
Levi’s could open more stores in the United States! Here’s what we know - Revista Merca2.0
Levi's Could Double U.S. Store Count, CEO Says - Bisnow
Levi Strauss (LEVI) Maintains 'Outperform' Rating from Telsey Ad - GuruFocus
Levi Strauss Stock Recovery Strengthens as Direct-to-Consumer Margins Expand - Investing.com
Levi Strauss & Co. stock price target raised to $26 by TD Cowen on DTC progress - Investing.com India
Levi Strauss Stock Set to Reach New Highs in 2026 - MarketBeat
Levi Strauss & Co. $LEVI Stake Boosted by OFI Invest Asset Management - MarketBeat
Levi Strauss & Co. (NYSE:LEVI) Shares Gap DownWhat's Next? - MarketBeat
Levi Strauss & Co. (NYSE:LEVI) Receives Outperform Rating from Telsey Advisory Group - MarketBeat
Levi Strauss & Co. (NYSE:LEVI) Given New $33.00 Price Target at JPMorgan Chase & Co. - MarketBeat
Levi Strauss slips as tariff-related costs overshadow forecast raise - ET BrandEquity
Morgan Stanley Raises Levi Strauss & Co. (NYSE:LEVI) Price Target to $20.00 - MarketBeat
Levi Strauss Reports Robust Growth Amid Challenges - TipRanks
Levi’s (LEVI) Profit Margin Surge Reinforces Bullish Valuation Narrative Despite Slower Growth Outlook - simplywall.st
Levi Strauss & Co. (NYSE:LEVI) Updates FY 2025 Earnings Guidance - MarketBeat
Levi Strauss Shares Fall as Tariff Costs Cloud Profit Outlook - TradingView
Levi Strauss (LEVI) Shares Drop Despite Strong Quarter - GuruFocus
Levi Strauss' Q3 Earnings Beat Estimates, DTC Sales Up 11.3% Y/Y - The Globe and Mail
Why Levi Strauss Stock is Tumbling Friday Despite Solid Earnings - MSN
Levi Strauss drops almost 12% over tariff woes - breakingthenews.net
Levi’s Q3 profit tops estimates as DTC drives sales; could double U.S. store count - Chain Store Age
Levi Strauss Drops 12% Post Earnings After Wall Street Raises Concerns On Margins - MSN
Levi Strauss Is Even More Fully Priced Than Before, Too Much Risk Ahead. (LEVI) - Seeking Alpha
Levi’s says it could double its US store count - Retail Dive
Why Levi's (LEVI) Stock Is Nosediving - FinancialContent
Levi Strauss lifts full-year guidance - Drapers
Levi Strauss Stock Falls as Profit Forecast Weighs - Schaeffer's Investment Research
Levi Strauss Faces Setback Despite Strong Q3 Performance - GuruFocus
Levi Strauss Stock Tanking After Q3 Is Buying Opportunity, Says Analyst - Benzinga
Levi Strauss (LEVI) reports a modest increase in Q3 2025 adj. earnings - AlphaStreet
Levi Strauss (LEVI): UBS Raises Price Target to $32.00 While Mai - GuruFocus
Levi Stock Is Trading Lower Friday: What's Going On? - Benzinga
Levi Strauss (LEVI) Shares Drop Significantly - GuruFocus
LEVI Stock Rating: Telsey Advisory Group Maintains 'Outperform' with $27 Price Target | LEVI Stock News - GuruFocus
Levi Strauss slips as FY profit forecast falls short of Street view - TradingView
Levi Strauss shares fall 9% as tariff-related costs overshadow forecast raise - The Economic Times
Levi Strauss & Co. ($LEVI) Stock: Shares Fall 8% Despite Strong Q3 Revenue Growth and Higher Full-Year Guidance - CoinCentral
Barclays Maintains Levi Strauss & Co.(LEVI.US) With Buy Rating, Maintains Target Price $26 - 富途牛牛
Levi’s shares slide as tariff concerns overshadow Q3 earnings beat - Proactive financial news
Levi Strauss (LEVI) Faces Potential Challenges Despite Strong Q3 Results - GuruFocus
US' Levi Strauss posts 7% YoY Q3 revenue growth, raises FY25 outlook - Fibre2Fashion
Nurix Therapeutics Posts Downbeat Q3 Results, Joins Orthopediatrics, Levi Strauss And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Benzinga
Stifel Reiterates Buy on Levi Strauss (LEVI), Cites Move to Higher-value Products, DTC Momentum - StreetInsider
Wells Fargo Maintains Levi Strauss & Co.(LEVI.US) With Buy Rating, Cuts Target Price to $25 - 富途牛牛
Levi's raises full-year outlook as DTC-first strategy pays off - TheIndustry.fashion
Levi Strauss & Co.'s (LEVI) Hold (C) Rating Reiterated at Weiss Ratings - MarketBeat
Finanzdaten der Levi Strauss Co-Aktie (LEVI)
Umsatz
Nettogewinn
Free Cashflow
ENV
9.02%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):